. 2019 Feb 15;155(5):999–1007. doi: 10.1016/j.chest.2019.02.007

Table 5.

Outcomes in RCT

Outcome	RPCR Group (n = 22)	Usual Care (n = 23)	P
Initial anti-MRSA treatment, h^a^,^b	32 (22-48)	72 (50-113)	<.001
28-d total anti-MRSA treatment, h^a	46 (24-73)	122 (66-219)	<.001
Duration of mechanical ventilation, h^a	132 (54-209)	158 (44-464)	.44
ICU length of stay, d^a	6 (5-14)	8 (6-26)	.19
Hospital length of stay, d^a	15 (10-24)	29 (12-44)	.07
Any adverse event, No. (%)	13 (59.1)	17 (73.9)	.29
Acute renal failure	4 (18.2)	5 (21.7)	1.00
Thrombocytopenia	5 (22.7)	6 (26.1)	.79
Nosocomial infection	8 (36.4)	12 (52.2)	.29
In-hospital mortality	3 (13.6)	9 (39.1)	.05

See Table 1 and 3 legends for expansion of abbreviations.

Median and interquartile range.

Primary end point.